BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

Inhibitory effects of polyphenols isolated from Rhus verniciflua on Aldo-keto reductase family 1 B10

  • Song, Dae-Geun (Natural Products Research Center, Korea Institute of Science and Technology Gangneung Institute) ;
  • Lee, Joo-Young (Natural Products Research Center, Korea Institute of Science and Technology Gangneung Institute) ;
  • Lee, Eun-Ha (Natural Products Research Center, Korea Institute of Science and Technology Gangneung Institute) ;
  • Jung, Sang-Hoon (Natural Products Research Center, Korea Institute of Science and Technology Gangneung Institute) ;
  • Nho, Chu-Won (Natural Products Research Center, Korea Institute of Science and Technology Gangneung Institute) ;
  • Cha, Kwang-Hyun (Natural Products Research Center, Korea Institute of Science and Technology Gangneung Institute) ;
  • Koo, Song-Yi (Natural Products Research Center, Korea Institute of Science and Technology Gangneung Institute) ;
  • Pan, Cheol-Ho (Natural Products Research Center, Korea Institute of Science and Technology Gangneung Institute)
  • Published : 2010.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Aldo-keto reductase family 1 B10 (AKR1B10) is a member of the NADPH-dependent aldo-keto reductase (AKR) superfamily, and has been considered to be a potential cancer therapeutic target. Total extract from the bark of Rhus verniciflua (Toxicodendron vernicifluum (Stokes)) showed AKR1B10 inhibitory activity. To identify the active compounds from R. verniciflua responsible for AKR1B10 inhibition, nine compounds were isolated via bioactivity-guided isolation and tested for their effects against recombinant human AKR1B10 (rhAKR1B10). Results showed that butein, isolated from the ethyl acetate fraction, was most able to inhibit rhAKR1B10. The inhibitory rate of butein against rhAKR1B10 was 42.86% at $1\;{\mu}M$ with an IC50 value of $1.47\;{\mu}M$, and enzyme kinetic analysis revealed its inhibition mode to be uncompetitive.

Keywords

References

  1. Cao, D., Fan, S. T. and Chung, S. S. (1998) Identification and characterization of a novel human aldose reductase-like gene. J. Biol. Chem. 273, 11429-11435 https://doi.org/10.1074/jbc.273.19.11429
  2. Crosas, B., Hyndman, D. J., Gallego, O., Martras, S., Pares, X., Flynn, T. G. and Farres, J. (2003) Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolism. Biochem J. 373, 973-979 https://doi.org/10.1042/BJ20021818
  3. Endo, S., Matsunaga, T., Mamiya, H., Ohta, C., Soda, M., Kitade, Y., Tajima, K., Zhao, H. T., El-Kabbani, O. and Hara, A. (2009) Kinetic studies of AKR1B10, human aldose reductase-like protein: endogenous substrates and inhibition by steroids. Arch. Biochem. Biophys. 487, 1-9 https://doi.org/10.1016/j.abb.2009.05.009
  4. Scuric, Z., Stain, S. C., Anderson, W. F. and Hwang, J. J. (1998) New member of aldose reductase family proteins overexpressed in human hepatocellular carcinoma. Hepatology. 27, 943-950 https://doi.org/10.1002/hep.510270408
  5. Fukumoto, S., Yamauchi, N., Moriguchi, H., Hippo, Y., Watanabe, A., Shibahara, J., Taniguchi, H., Ishikawa, S., Ito, H., Yamamoto, S., Iwanari, H., Hironaka, M., Ishikawa, Y., Niki, T., Sohara, Y., Kodama, T., Nishimura, M., Fukayama, M., Dosaka-Akita, H. and Aburatani, H. (2005) Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' nonsmall cell lung carcinomas. Clin. Cancer. Res. 11, 1776-1785 https://doi.org/10.1158/1078-0432.CCR-04-1238
  6. Yoshitake, H., Takahashi, M., Ishikawa, H., Nojima, M., Iwanari, H., Watanabe, A., Aburatani, H., Yoshida, K., Ishi, K., Takamori, K., Ogawa, H., Hamakubo, T., Kodama, T. and Araki, Y. (2007) Aldo-keto reductase family 1, member B10 in uterine carcinomas: a potential risk factor of recurrence after surgical therapy in cervical cancer. Int. J. Gynecol. Cancer. 17, 1300-1306 https://doi.org/10.1111/j.1525-1438.2007.00932.x
  7. Penning, T. M. (2005) AKR1B10: a new diagnostic marker of non-small cell lung carcinoma in smokers. Clin. Cancer. Res. 11, 1687-1690 https://doi.org/10.1158/1078-0432.CCR-05-0071
  8. Yan, R., Zu, X., Ma, J., Liu, Z., Adeyanju, M. and Cao, D. (2007) Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: implication for cancer intervention. Int. J. Cancer. 121, 2301-2306 https://doi.org/10.1002/ijc.22933
  9. Ma, J., Yan, R., Zu, X., Cheng, J. M., Rao, K., Liao, D. F. and Cao, D. (2008) Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells. J. Biol. Chem. 283, 3418-3423 https://doi.org/10.1074/jbc.M707650200
  10. Wang, C., Yan, R., Luo, D., Watabe, K., Liao, D. F. and Cao, D. (2009) Aldo-keto reductase family 1 member B10 promotes cell survival by regulating lipid synthesis and eliminating carbonyls. J. Biol. Chem. 284, 26742-26748
  11. Frank, R. N., Keirn, R. J., Kennedy, A. and Frank, K. W. (1983) Galactose-induced retinal capillary basement membrane thickening: prevention by Sorbinil. Invest. Ophthalmol. Vis. Sci. 24, 1519-1524
  12. Young, R. J., Ewing, D. J. and Clarke, B. F. (1983) A controlled trial of sorbinil, an aldose reductase inhibitor, in chronic painful diabetic neuropathy. Diabetes. 32, 938-942 https://doi.org/10.2337/diabetes.32.10.938
  13. Dunlop, M. (2000) Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int. Suppl. 77, S3-12 https://doi.org/10.1038/ki.2009.458
  14. Robison, W. G., Jr., Nagata, M., Laver, N., Hohman, T. C. and Kinoshita, J. H. (1989) Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor. Invest. Ophthalmol. Vis. Sci. 30, 2285-2292
  15. Gallego, O., Ruiz, F. X., Ardevol, A., Dominguez, M., Alvarez, R., de Lera, A. R., Rovira, C., Farres, J., Fita, I. and Pares, X. (2007) Structural basis for the high alltrans-retinaldehyde reductase activity of the tumor marker AKR1B10. Proc. Natl. Acad. Sci. U.S.A. 104, 20764-20769 https://doi.org/10.1073/pnas.0705659105
  16. Spite, M., Baba, S. P., Ahmed, Y., Barski, O. A., Nijhawan, K., Petrash, J. M., Bhatnagar, A. and Srivastava, S. (2007) Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes. Biochem. J. 405, 95-105 https://doi.org/10.1042/BJ20061743
  17. Lee, E. H., Song, D. G., Lee, J. Y., Pan, C. H., Um, B. H. and Jung, S. H. (2008) Inhibitory effect of the compounds isolated from Rhus verniciflua on aldose reductase and advanced glycation endproducts. Biol. Pharm. Bull. 31, 1626-1630 https://doi.org/10.1248/bpb.31.1626
  18. Jung, C. H., Kim, J. H., Hong, M. H., Seog, H. M., Oh, S. H., Lee, P. J., Kim, G. J., Kim, H. M., Um, J. Y. and Ko, S. G. (2007) Phenolic-rich fraction from Rhus verniciflua Stokes (RVS) suppress inflammatory response via NFappaB and JNK pathway in lipopolysaccharide-induced RAW 264.7 macrophages. J. Ethnopharmacol. 110, 490-497 https://doi.org/10.1016/j.jep.2006.10.013
  19. Samoszuk, M., Tan, J. and Chorn, G. (2005) The chalcone butein from Rhus verniciflua Stokes inhibits clonogenic growth of human breast cancer cells co-cultured with fibroblasts. BMC. Complement. Altern. Med. 5, 5 https://doi.org/10.1186/1472-6882-5-5
  20. Pan, C. H., Lee, J. Y., Song. D. G., Kim, J. H., Ahn, S. Y., Bae, D. S., Kim, Y. H. and Lee, J. K. (2009) Antioxidant and Aldo-keto reductase family 1 B10 inhibition activities of Korean local plant extracts. J. Appl. Biol. Chem. 52, 216-220 https://doi.org/10.3839/jabc.2009.037
  21. Matsunaga, T., Endo, S., Soda, M., Zhao, H. T., El- abbani, O., Tajima, K. and Hara, A. (2009) Potent and selective inhibition of the tumor marker AKR1B10 by bisdemethoxycurcumin: probing the active site of the enzyme with molecular modeling and site-directed mutagenesis. Biochem. Biophys. Res. Commun. 389, 128-132 https://doi.org/10.1016/j.bbrc.2009.08.107
  22. Lee, J. Y., Song, D. G., Lee, E. H., Jung, S. H., Nho, C. W., Cha, K. H. and Pan, C. H. (2009) Inhibitory effects of 3,5-O-dicaffeoyl-epi-quinic acid from Gymnaster koraiensis on AKR1B10. J. Korean. Soc. Appl. Biol. Chem. 52, 731-734 https://doi.org/10.3839/jksabc.2009.121
  23. Zhang, L., Chen, W. and Li, X. (2008) A novel anticancer effect of butein: inhibition of invasion through the ERK1/2 and NF-kappa B signaling pathways in bladder cancer cells. FEBS. Lett. 582, 1821-1828 https://doi.org/10.1016/j.febslet.2008.04.046
  24. Moon, D. O., Kim, M. O., Choi, Y. H., Hyun, J. W., Chang, W. Y. and Kim, G. Y. (2010) Butein induces G(2)/phase arrest and apoptosis in human hepatoma cancer cells through ROS generation. Cancer Lett. 288, 204-213 https://doi.org/10.1016/j.canlet.2009.07.002
  25. de la Fuente, J. A. and Manzanaro, S. (2003) Aldose reductase inhibitors from natural sources. Nat. Prod. Rep. 20, 243-251 https://doi.org/10.1039/b204709h
  26. Lee, J. Y., Song, D. G,. Jung, S. H., Kim, J. H., Ahn, S. Y., Nho, C. W. and Pan, C. H. (2009) Inhibitory effects of Korean local plant extracts on AKR1B10. Korean J. Pharmacognosy. 40, 238-243
  27. Sato, S. and Kador, P. F. (1990) Inhibition of aldehyde reductase by aldose reductase inhibitors. Biochem. Pharmacol. 40, 1033-1042 https://doi.org/10.1016/0006-2952(90)90490-C

Cited by

  1. AKR1B10-inhibitory Selaginella tamariscina extract and amentoflavone decrease the growth of A549 human lung cancer cells in vitro and in vivo vol.202, 2017, https://doi.org/10.1016/j.jep.2017.03.010
  2. Butein: From ancient traditional remedy to modern nutraceutical vol.11, 2015, https://doi.org/10.1016/j.phytol.2014.12.014
  3. Rhus vernicifluaStokes against Advanced Cancer: A Perspective from the Korean Integrative Cancer Center vol.2012, 2012, https://doi.org/10.1155/2012/874276
  4. X-ray structure of the V301L aldo–keto reductase 1B10 complexed with NADP+ and the potent aldose reductase inhibitor fidarestat: Implications for inhibitor binding and selectivity vol.202, pp.1-3, 2013, https://doi.org/10.1016/j.cbi.2012.12.013
  5. Flavones Inhibit the Activity of AKR1B10, a Promising Therapeutic Target for Cancer Treatment vol.78, pp.11, 2015, https://doi.org/10.1021/acs.jnatprod.5b00616
  6. Efficacy and Safety of Standardized Allergen-Removed Rhus verniciflua Stokes Extract in Patients with Advanced or Metastatic Pancreatic Cancer: A Korean Single-Center Experience vol.81, pp.5-6, 2011, https://doi.org/10.1159/000334695
  7. Phlorofucofuroeckol-A, a potent inhibitor of aldo-keto reductase family 1 member B10, from the edible brown alga Eisenia bicyclis vol.55, pp.6, 2012, https://doi.org/10.1007/s13765-012-2169-3
  8. Integrating Traditional Medicine into Modern Inflammatory Diseases Care: Multitargeting byRhus vernicifluaStokes vol.2014, 2014, https://doi.org/10.1155/2014/154561